Table 3.
Group | Hazard Ratio | 95% Confidence Interval | p-Value |
---|---|---|---|
T1/T2 LVI− | referent | referent | |
T1/T2 LVI+ | 1.8 | 1.4–2.3 | <0.001 |
T3 LVI− | 2.1 | 1.8–2.5 | <0.001 |
T3 LVI+ | 3.7 | 3.1–4.3 | <0.001 |
T4 LVI− | 5.3 | 4.0–7.1 | <0.001 |
T4 LVI+ | 7.1 | 5.8–8.7 | <0.001 |
Multivariate competing-risks regression analysis adjusted for age, sex, race, Charlson–Deyo score, WHO grade, pathological N category, surgical margin status, and chemotherapy administration. Cofactors with statistically significant independent effects included (hazard ratios, 95% confidence intervals in parentheses): older age (continuous) (1.03, 1.02–1.04), Charlson–Deyo score ≥2 (1.5, 1.3–1.8), pathologic N+ (1.5, 1.3–1.7), high grade (1.9, 1.5–2.4), unknown grade (2.0, 1.4–2.7), positive surgical margins (2.0, 1.8–2.4), unknown surgical margins (1.5, 1.0–2.2), and chemotherapy administered (0.8, 0.7–0.9).